Please login to the form below

Not currently logged in
PMLiVE Top Pharma List

Nippon Shinyaku

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nippon Shinyaku's Japan sales performance.


Breathing easier

Daxas (Nycomed). Chronic obstructive pulmonary desease. Germany, UK. Tramadol. Tramal Capsule (Nippon Shinyaku).

Breathing easier

Dexamethasone cipecilate dry powder. Erizas capsule for Nasal spray 400μg (Nippon Shinyaku). ... Adcirca (Nippon Shinyaku). Pulmonary hypertension  . Japan.  . The Author. Pipeline was written by Tori Muir of Adis International  - Wolters Kluwer

Biologics at forefront

163. Spectrum Pharmaceuticals/Nippon Kayaku. Apaziquone (bladder cancer)    . PIII . 151. Syntiron/sanofi-aventis .

Breathing life

Breathing life Erizas capsule for Nasal spray 400μg (Nippon Shinyaku). Allergic rhinitis. Japan. ... Galactiv (Ono Pharmaceutical). Type-2 diabetes mellitus. Japan. Tadalafil. Adcirca (Nippon Shinyaku).

Pandemic preparedness

Micombi (Nippon Boehringer Ingelheim, Astellas Pharma). Hypertension. Japan. Triptorelin. Salvacyl (Debiopharm).

[ Previous 5 results ] 1 2 3 4 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company Events and Exhibition Stands is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...